Search This Blog

Monday, January 30, 2023

Philips sees some improvement in Q; actions to address operational challenges

 Fourth-quarter highlights

  • Group sales amounted to EUR 5.4 billion, with 3% comparable sales growth driven by component supply improvements, while Philips’ supply chain conditions remain challenging
  • Comparable order intake decreased 8%, due to lower demand for COVID-19-related products compared to 2021 and company actions to improve the order book margin profile
  • Income from operations amounted to EUR 171 million, compared to EUR 162 million in Q4 2021
  • Adjusted EBITA of EUR 651 million, or 12.0% of sales, compared to EUR 647 million, or 13.1% of sales, in Q4 2021
  • Operating cash flow was EUR 540 million, compared to EUR 720 million in Q4 2021

Full-year highlights

  • Group sales amounted to EUR 17.8 billion, with a 3% comparable sales decline due to operational and supply challenges, lower sales in China, the consequences of the Respironics field action, and the Russia-Ukraine war
  • Comparable order intake decreased 3% compared to 4% growth in 2021
  • Income from operations amounted to a loss of EUR 1,529 million, largely due to the previously disclosed EUR 1.5 billion non-cash goodwill and R&D impairment charges, compared to income of EUR 553 million in 2021
  • Adjusted EBITA of EUR 1,318 million, or 7.4% of sales, compared to EUR 2,054 million, or 12.0% of sales, in 2021
  • Operating cash outflow of EUR 173 million, compared to an inflow of EUR 1,629 million in 2021
  • Proposed dividend maintained at EUR 0.85 per share, to be distributed in shares

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.